Global Phage MuA Transposase Market Growth 2025-2031
Description
The global Phage MuA Transposase market size is predicted to grow from US$ 317 million in 2025 to US$ 526 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
MuA transposase is derived from the MuA gene of bacteriophage Mu, which can catalyze the insertion of DNA from bacteriophage Mu into the host genome, or cut out from the host genome and transfer to other locations. The recombinantly expressed product can catalyze the insertion of donor genes into receptor DNA, and complete the transposition by recognizing the IR sequence, forming a transposition complex (4-mer), cutting the target DNA and reconnecting it.
The price of MuA transposase varies by supplier, product specifications and region, and is generally between $100 and $1,300 per unit. With the rapid development of genome editing and functional genomics research, the market demand for MuA transposase continues to grow. According to a report by Verified Market Research, the molecular biology enzyme and reagent market is expected to grow from $19.3 billion in 2023 to $69.4 billion in 2031, with an average annual growth rate of 17.35%. This trend has promoted the widespread use of MuA transposase in scientific research and industrial applications, especially in high-throughput mutation library construction and genome integration research. At the same time, suppliers continue to launch efficient and low-cost MuA transposase products to meet the market demand for high-quality scientific research reagents.
United States market for Phage MuA Transposase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Phage MuA Transposase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Phage MuA Transposase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Phage MuA Transposase players cover Domus Biotechnologies, Thermo Fisher Scientific, MyBioSource, Addgene, Sigma-Aldrich, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Phage MuA Transposase Industry Forecast” looks at past sales and reviews total world Phage MuA Transposase sales in 2024, providing a comprehensive analysis by region and market sector of projected Phage MuA Transposase sales for 2025 through 2031. With Phage MuA Transposase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage MuA Transposase industry.
This Insight Report provides a comprehensive analysis of the global Phage MuA Transposase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phage MuA Transposase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phage MuA Transposase market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage MuA Transposase and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage MuA Transposase.
This report presents a comprehensive overview, market shares, and growth opportunities of Phage MuA Transposase market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Standard Active Enzyme
High Concentration Enzyme
Segmentation by Application:
Biopharmaceuticals
Vaccine Development
Functional Genomics Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Domus Biotechnologies
Thermo Fisher Scientific
MyBioSource
Addgene
Sigma-Aldrich
New England Biolabs
Promega
Bio-Rad Laboratories
Qiagen
Lucigen
Takara Bio
Invitrogen
Clontech
Cell Biolabs
Bio-Techne
Key Questions Addressed in this Report
What is the 10-year outlook for the global Phage MuA Transposase market?
What factors are driving Phage MuA Transposase market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phage MuA Transposase market opportunities vary by end market size?
How does Phage MuA Transposase break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
MuA transposase is derived from the MuA gene of bacteriophage Mu, which can catalyze the insertion of DNA from bacteriophage Mu into the host genome, or cut out from the host genome and transfer to other locations. The recombinantly expressed product can catalyze the insertion of donor genes into receptor DNA, and complete the transposition by recognizing the IR sequence, forming a transposition complex (4-mer), cutting the target DNA and reconnecting it.
The price of MuA transposase varies by supplier, product specifications and region, and is generally between $100 and $1,300 per unit. With the rapid development of genome editing and functional genomics research, the market demand for MuA transposase continues to grow. According to a report by Verified Market Research, the molecular biology enzyme and reagent market is expected to grow from $19.3 billion in 2023 to $69.4 billion in 2031, with an average annual growth rate of 17.35%. This trend has promoted the widespread use of MuA transposase in scientific research and industrial applications, especially in high-throughput mutation library construction and genome integration research. At the same time, suppliers continue to launch efficient and low-cost MuA transposase products to meet the market demand for high-quality scientific research reagents.
United States market for Phage MuA Transposase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Phage MuA Transposase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Phage MuA Transposase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Phage MuA Transposase players cover Domus Biotechnologies, Thermo Fisher Scientific, MyBioSource, Addgene, Sigma-Aldrich, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Phage MuA Transposase Industry Forecast” looks at past sales and reviews total world Phage MuA Transposase sales in 2024, providing a comprehensive analysis by region and market sector of projected Phage MuA Transposase sales for 2025 through 2031. With Phage MuA Transposase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage MuA Transposase industry.
This Insight Report provides a comprehensive analysis of the global Phage MuA Transposase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phage MuA Transposase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phage MuA Transposase market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage MuA Transposase and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage MuA Transposase.
This report presents a comprehensive overview, market shares, and growth opportunities of Phage MuA Transposase market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Standard Active Enzyme
High Concentration Enzyme
Segmentation by Application:
Biopharmaceuticals
Vaccine Development
Functional Genomics Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Domus Biotechnologies
Thermo Fisher Scientific
MyBioSource
Addgene
Sigma-Aldrich
New England Biolabs
Promega
Bio-Rad Laboratories
Qiagen
Lucigen
Takara Bio
Invitrogen
Clontech
Cell Biolabs
Bio-Techne
Key Questions Addressed in this Report
What is the 10-year outlook for the global Phage MuA Transposase market?
What factors are driving Phage MuA Transposase market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phage MuA Transposase market opportunities vary by end market size?
How does Phage MuA Transposase break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
106 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Phage MuA Transposase by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Phage MuA Transposase by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
